Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
Kinco Automation (Shanghai) Co.,Ltd
688160
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
AMRN Amarin
- 0.547
- -0.023-4.00%
Close Jan 22 16:00 ET
- 0.565
- +0.018+3.33%
Post 20:01 ET
224.92MMarket Cap-5.47P/E (TTM)
0.580High0.541Low793.38KVolume0.580Open0.570Pre Close442.63KTurnover0.21%Turnover RatioLossP/E (Static)411.34MShares1.37052wk High0.42P/B209.81MFloat Cap0.43052wk Low--Dividend TTM383.70MShs Float675.000Historical High--Div YieldTTM6.83%Amplitude0.430Historical Low0.557Avg Price1Lot Size
About Amarin Company
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Company Profile
SymbolAMRN
Company NameAmarin
Listing DateApr 1, 1993
Issue Price6.00
Founded1989
CEOMr. Aaron D. Berg
MarketNASDAQ
Employees275
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressIconic Offices, The Greenway,Block C Ardilaun Court, 112–114,St. Stephens Green
CityDublin
ProvinceDublin
CountryIreland
Zip Code2
Phone353-1-6699-020
Websitehttp://www.amarincorp.com
Company Executives
- Name
- Position
- Salary
- Aaron D. Berg
- Director, President and Chief Executive Officer
- 2.45M
- Peter Fishman
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Steven B. Ketchum, PhD
- Executive Vice President, President, Research and Development and Chief Scientific Officer
- 2.35M
- Jonathan N. Provoost
- Executive Vice President, Chief Legal and Compliance Officer and Secretary
- 659.26K
- Dr. Odysseas D. Kostas, M.D.
- Chairman of the Board
- 650.41K
- Patrice Bonfiglio
- Independent Director
- 626.87K
- Diane E. Sullivan
- Independent Director
- 630.83K
- Mark DiPaolo, Esq.
- Independent Director
- 621.00K
- Louis Sterling, III
- Independent Director
- 629.35K
- Keith L. Horn
- Independent Director
- 632.09K
- Dr. Paul Cohen, M.D.
- Independent Director
- 622.06K
- Oliver O'Connor
- Independent Director
- 611.85K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
As Tesla's earnings near, will its stock soar?
🎙️Discussion: 1. With Trump's return, can Tesla's stock price continue to rise in 2025? 2. Tesla is set to release its earnings report aft
BullnBearTrading
Jan 3 16:30
🚗 Tesla Q4 Dip: Time to Buy , or Is the Risk Too High? 📉